UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive (Loss)
Balance, beginning of period (in shares) at Dec. 31, 2021		81,712
Balance, beginning of period at Dec. 31, 2021	$ 416,088	$ 817	$ 145,810	$ 276,449	$ (6,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)		(242)
Repurchase of common stock	(22,583)	$ (2)	(22,581)
Issuance of common stock for stock compensation plans (in shares)		297
Issuance of common stock for stock compensation plans	(12,128)	$ 3	(12,131)
Issuance of common stock under the employee stock purchase plan (in shares)		35
Issuance of common stock under the employee stock purchase plan	2,446		2,446
Stock-based compensation	28,227		28,227
Cash dividends declared ($0.03 per share)	(2,455)			(2,455)
Other comprehensive (loss) income	(2,548)				(2,548)
Net (loss)	(379)			(379)
Balance, end of period (in shares) at Mar. 31, 2022		81,802
Balance, end of period at Mar. 31, 2022	$ 406,668	$ 818	141,771	273,615	(9,536)
Balance, beginning of period (in shares) at Dec. 31, 2022	82,436	82,436
Balance, beginning of period at Dec. 31, 2022	$ 130,843	$ 824	229,602	(76,513)	(23,070)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for stock compensation plans (in shares)		452
Issuance of common stock for stock compensation plans	672	$ 4	668
Issuance of common stock under the employee stock purchase plan (in shares)		52
Issuance of common stock under the employee stock purchase plan	2,143	$ 1	2,142
Stock-based compensation	42,557		42,557
Cash dividends declared ($0.03 per share)	(2,488)		(2,488)
Other comprehensive (loss) income	1,543				1,543
Net (loss)	$ (20,774)			(20,774)
Balance, end of period (in shares) at Mar. 31, 2023	82,940	82,940
Balance, end of period at Mar. 31, 2023	$ 154,496	$ 829	$ 272,481	$ (97,287)	$ (21,527)